Relationship between mTHPC fluorescence photobleaching and cell viability during in vitro photodynamic treatment of DP16 cells

Photochemistry and Photobiology

Volumn 75, Issue 3, 2002, Pages 289-295

  Dysart, Jonathan S ^a,b   Patterson, Michael S ^a,b   Farrell, Thomas J ^a,b   Singh, Gurmit ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b JURAVINSKI CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORINE DERIVATIVE; PHOTOSENSITIZING AGENT; TETRAHYDROXYPHENYLCHLORINE; TRYPAN BLUE; UNCLASSIFIED DRUG; MESOPORPHYRIN; TEMOPORFIN;

ANIMAL CELL; ARTICLE; BIOLOGICAL MONITORING; BLEACHING; CELL VIABILITY; CHARGE COUPLED DEVICE COUPLED SPECTROMETRY; CONCENTRATION PROCESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEVICE; DOSIMETRY; IN VITRO STUDY; INCUBATION TIME; MOUSE; NONHUMAN; OXYGENATION; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PREDICTION; RADIATION RESPONSE; REACTION OPTIMIZATION; SENSITIVITY ANALYSIS; ANIMAL; CELL SURVIVAL; DRUG EFFECT; PHOTOCHEMOTHERAPY; SPECTROFLUOROMETRY;

ANIMALIA;

ANIMALS; CELL SURVIVAL; MESOPORPHYRINS; MICE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SPECTROMETRY, FLUORESCENCE;

EID: 0036516435     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/0031-8655(2002)075<0289:RBMFPA>2.0.CO;2     Document Type: Article

References (29)

1. Schuitmaker, J. J., P. Baas, H. L. van Leengoed, F. W. van der Meulen, W. M. Star and N. van Zandwijk (1996) Photodynamic therapy: a promising new modality for the treatment of cancer. J. Photochem. Photobiol. B 34, 3-12.
2. Radu, A., G. Wagnieres, H. van den Bergh and P. Monnier (2001) Photodynamic therapy of early squamous cell cancers of the esophagus. Gastrointest. Endosc. Clin. N. Am. 10, 439-460.
3. Janssen, W. G. (1996) Photodynamic therapy: a guide to instrumentation and dosimetry calculations. Minim. Invasive Surg. Nurs. 10, 105-108.
4. Braichotte, D. R., J. F. Savary, P. Monnier and H. E. van den Bergh (1996) Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy. Lasers Surg. Med. 19, 340-346.
5. Zelweger, M., P. Grosjean, P. Monnier, H. van den Bergh and G. Wagnieres (1999) Stability of the fluorescence measurement of Foscan in the normal human oral cavity as an indicator of its content in early cancers of the esophagus and the bronchi. Photochem. Photobiol. 69, 605-610.
6. Potter, W. R. (1986) The theory of photodynamic therapy dosimetry: consequences of photodestruction of sensitizer. Lasers Surg. Med. 712, 124-129.
7. Spikes, J. D. (1992) Quantum yields and kinetics of the photobleaching of hematoporphyrin, Photofrin II, tetra(4-sulfonatophenyl)-porphine and uroporphyrin. Photochem. Photobiol. 55, 797-808.
8. Mang, T. S., T. J. Dougherty, W. R. Potter, D. G. Boyle, S. Somer and J. Moan (1987) Photobleaching of porphyrins used in photodynamic therapy and implications for therapy. Photochem. Photobiol. 45, 501-506.
9. Finlay, J. C., D. L. Conover, E. L. Hull and T. H. Foster (2001) Porphyrin bleaching and PDT-induced spectral changes are irradiance dependent in ALA-sensitized normal rat skin in vivo. Photochem. Photobiol. 73, 54-63.
10. Robinson, D. J., H. S. de Bruijn, N. van der Veen, M. R. Stringer, S. B. Brown and W. M. Star (1998) Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem. Photobiol. 67, 140-149.
11. Forrer, M., T. Glanzmann, H. van den Bergh, J. Savary and P. Monnier (1995) In vivo measurement of fluorescence bleaching of meso-tetra hydroxyphenyl chlorin (mTHPC) in the esophagus and the oral cavity. Proc. SPIE 2624, 33-39.
12. Foster, T. H. and L. Gao (1992) Dosimetry in photodynamic therapy: oxygen and the critical importance of capillary density. Radiat. Res. 130, 379-383.
13. Iinuma, S., K. T. Schomacker, G. Wagnieres, M. Rajadhyaksha, M. Bamberg, T. Momma and T. Hasan (1999) In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. Cancer Res. 59, 6164-6170.
14. Henderson, B. W., T. M. Busch, L. A. Vaughan, N. P. Frawley, D. Babich, T. A. Sosa, J. D. Zollo, A. S. Dee, M. T. Cooper, D. A. Bellnier, W. R. Greco and A. R. Oseroff (2000) Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. Cancer Res. 60, 525-529.
15. Muller, S., H. Walt, D. Dobler-Girdziunaite, D. Fiedler and U. Haller (1998) Enhanced photodynamic effects using fractionated laser light. J. Photochem. Photobiol. B 42, 67-70.
16. Tromberg, B. J., A. Orenstein, S. Kimel, S. J. Barker, J. Hyatt, J. S. Nelson and M. W. Berns (1990) In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochem. Photobiol. 52, 375-385.
17. Wilson, B. C., M. S. Patterson and L. Lilge (1997) Implicit and explicit dosimetry in photodynamic therapy: a new paradigm. Lasers Med. Sci. 12, 182-199.
18. Georgakoudi, I., M. G. Nichols and T. H. Foster (1997) The mechanism of Photofrin photobleaching and its consequences for photodynamic dosimetry. Photochem. Photobiol. 65, 135-144.
19. Bezdetnaya, L., N. Zeghari, I. Belitchenko, M. Barberi-Heyob, J. L. Merlin, A. Potapenko and F. Guillemin (1996) Spectroscopic and biological testing of photobleaching of porphyrins in solutions. Photochem. Photobiol. 64, 382-386.
20. Aalders, M. C., H. J. Sterenborg, F. A. Stewart and N. van der Vange (2000) Photodetection with 5-aminolevulinic acid-induced protoporphyrin IX in the rat abdominal cavity: drug-dose-dependent fluorescence kinetics. Photochem. Photobiol. 72, 521-525.
21. Glanzmann, T., C. Hadjur, M. Zellweger, P. Grosiean, M. Forrer, J. P. Ballini, P. Monnier, H. van den Bergh, C. K. Lim and G. Wagnieres (1998) Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy. Photochem. Photobiol. 67, 596-602.
22. Peng, Q. and J. Moan (1995) Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma. Br. J. Cancer 72, 565-574.
23. Ma, L. W., J. Moan and K. Berg (1994) Comparison of the photobleaching effect of three photosensitizing agents: mesotetra(m-hydroxyphenyl)chlorin, meso-tetra(m-hydroxyphenyl)porphyrin and photofrin during photodynamic therapy. Lasers Med. Sci. 9, 127-132.
24. Ma, L., J. Moan and K. Berg (1994) Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers. Int. J. Cancer 57, 883-888.
25. van Geel, I. P., H. Oppelaar, Y. G. Oussoren, M. A. van der Valk and F. A. Stewart (1995) Photosensitizing efficacy of MTHPC-PDT compared to photofrin-PDT in the RIF1 mouse tumour and normal skin. Int. J. Cancer 60, 388-394.
26. Bonnett, R., R. D. White, U. J. Winfield and M. C. Berenbaum (1989) Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. Biochem. J. 261, 277-280.
27. Henderson, B. W. and V. H. Fingar (1987) Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res. 47, 3110-3114.
28. Chapman, J. D., C. C. Stobbe, M. R. Arnfield, R. Santus, J. Lee and M. S. McPhee (1991) Oxygen dependency of tumor cell killing in vitro by light-activated Photofrin II. Radiat. Res. 126, 73-79.
29. Melnikova, V. O., L. N. Bezdetnaya, A. Y. Potapenko and F. Guillemin (1999) Photodynamic properties of meta-tetra(hydroxyphenyl)chlorin in human tumor cells. Radiat. Res. 152, 428-435.